Th17 cells, in particular, are identified as key effector cells in the chronic inflammatory process of MS, serving as the main source of inflammatory cytokines like IL‐17, IL‐21, and IL‐22 [141]. This evidence concerns the gene IL17A and myeloid sarcoma.